Sultan Linjawi

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

Stephen Gough, Bruce W. Bode, Vincent Woo et al. · The Lancet Diabetes & Endocrinology · 2014 · 351 citations

Diabetes Management, Insulin Degludec, Diabetes +9

The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial

Sultan Linjawi, Bruce W. Bode, Louis Chaykin et al. · Diabetes Therapy · 2016 · 130 citations · Full text

One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial

Stephen Gough, Bruce W. Bode, Vincent Woo et al. · Diabetes Obesity and Metabolism · 2015 · 122 citations · Full text

Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course

Julia Lowe, Sultan Linjawi, M. Mensch et al. · Diabetes Research and Clinical Practice · 2008 · 98 citations

Obesity, Nutrition, Diabetes Management +12

IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

Jens J. Holst, John B. Buse, Helena W. Rodbard et al. · Journal of Diabetes Science and Technology · 2015 · 26 citations · Full text